StockNews.com initiated coverage on shares of NuVasive (NASDAQ:NUVA – Free Report) in a research note published on Saturday. The brokerage issued a hold rating on the medical device company’s stock. NUVA has been the topic of a number of other research reports. Barclays raised their target price on shares of NuVasive from $53.00 to $56.00 […]